Carina Biotech
PrivateLast Round
Early Funding
Apr 15, 2025
Total Funding Raised
$14.58M
Company Overview
Carina Biotech operates in Healthcare & Life Sciences and is based in Mawson Lakes. Its latest recorded funding round was an Early Funding round in April 2025.
Carina Biotech is a biotechnology company that researches and develops chimeric antigen receptor T cell (CAR-T) therapies to treat solid cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Carina Biotech Comparables
Compare Carina Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Invectys | 80% | |
| AffyImmune Therapeutics | 78% | |
| A2 Biotherapeutics | 77% |
For institutional investors. Book with your work email.
Carina Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 15, 2025 | ||||
| Series A | Aug 15, 2022 | ||||
| Early Funding | Sep 1, 2021 | ||||
| Grant | Apr 23, 2020 |
For institutional investors. Book with your work email.
Carina Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Minderoo Foundation | Series A, Early Funding |
| University of Adelaide | Series A |
| Tenmile | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 34% MoM, reaching 3.2K.
- Dec 22, 2025
Grew 19% QoQ, from 16 to 19 employees.
For institutional investors. Book with your work email.
Carina Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Carina Biotech's valuation, stock price, and market status.
Is Carina Biotech a public or private company?
Carina Biotech is a private company.
What is the current stock price of Carina Biotech?
Carina Biotech is a private company, so its shares have no public market price. Caplight tracks Carina Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Carina Biotech worth (valuation)?
Valuation information for Carina Biotech is not publicly available.
Can I buy Carina Biotech stock?
Carina Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Carina Biotech's last funding round?
Carina Biotech's most recent funding round was Early Funding on April 15, 2025.
Who are the main investors in Carina Biotech?
Key investors in Carina Biotech include Minderoo Foundation, Tenmile.
Will Carina Biotech IPO soon?
No public IPO plans have been announced for Carina Biotech.
How can I track Carina Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Carina Biotech's shares on secondary markets.